Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa

BACKGROUND: While the mechanism of action by which azithromycin exerts positive effects in patients with cystic fibrosis remains unclear, evidence suggests that azithromycin may act as an immunomodulatory agent. We examined changes in systemic inflammatory markers in a double-blind, randomized, cont...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ratjen, Felix, Saiman, Lisa, Mayer-Hamblett, Nicole, Lands, Larry C., Kloster, Margaret, Thompson, Valeria, Emmett, Peggy, Marshall, Bruce, Accurso, Frank, Sagel, Scott, Anstead, Michael
Формат: Artigo
Язык:Inglês
Опубликовано: American College of Chest Physicians 2012
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3610595/
https://ncbi.nlm.nih.gov/pubmed/22595153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.12-0628
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы